Fidelity Investments’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-183,229
| Closed | -$13.2M | – | 5543 |
|
|
2025
Q4 | $13.2M | Sell |
183,229
-21,402,755
| -99% | -$1.38B | ﹤0.01% | 1923 |
|
|
2025
Q3 | $941M | Buy |
21,585,984
+5,400,193
| +33% | +$218M | 0.05% | 309 |
|
|
2025
Q2 | $460M | Buy |
16,185,791
+570,727
| +4% | +$17M | 0.03% | 513 |
|
|
2025
Q1 | $461M | Sell |
15,615,064
-894,542
| -5% | -$27.9M | 0.03% | 487 |
|
|
2024
Q4 | $480M | Sell |
16,509,606
-339,170
| -2% | -$14.2M | 0.03% | 482 |
|
|
2024
Q3 | $774M | Buy |
16,848,776
+689,729
| +4% | +$29.9M | 0.05% | 342 |
|
|
2024
Q2 | $660M | Buy |
16,159,047
+1,917,411
| +13% | +$55M | 0.04% | 352 |
|
|
2024
Q1 | $363M | Buy |
14,241,636
+3,837,540
| +37% | +$60.1M | 0.02% | 559 |
|
|
2023
Q4 | $94.2M | Sell |
10,404,096
-710,335
| -6% | -$4.75M | 0.01% | 1038 |
|
|
2023
Q3 | $70.9M | Buy |
11,114,431
+491,567
| +5% | +$4.24M | 0.01% | 1116 |
|
|
2023
Q2 | $118M | Buy |
10,622,864
+5,203,807
| +96% | +$65.3M | 0.01% | 918 |
|
|
2023
Q1 | $83.2M | Buy |
5,419,057
+493,679
| +10% | +$10.9M | 0.01% | 1049 |
|
|
2022
Q4 | $109M | Buy |
4,925,378
+1,453,059
| +42% | +$21.7M | 0.01% | 937 |
|
|
2022
Q3 | $56.7M | Sell |
3,472,319
-336,804
| -9% | -$6.44M | 0.01% | 1200 |
|
|
2022
Q2 | $55.3M | Sell |
3,809,123
-1,792
| -0% | -$26.7K | 0.01% | 1214 |
|
|
2022
Q1 | $70.4M | Buy |
3,810,915
+34,391
| +0.9% | +$584K | 0.01% | 1247 |
|
|
2021
Q4 | $89.8M | Sell |
3,776,524
-57,143
| -1% | -$1.36M | 0.01% | 1150 |
|
|
2021
Q3 | $94.4M | Buy |
3,833,667
+439,352
| +13% | +$9.55M | 0.01% | 1129 |
|
|
2021
Q2 | $83.9M | Sell |
3,394,315
-39,273
| -1% | -$914K | 0.01% | 1199 |
|
|
2021
Q1 | $74.9M | Buy |
3,433,588
+9,453
| +0.3% | +$231K | 0.01% | 1207 |
|
|
2020
Q4 | $87.4M | Buy |
3,424,135
+405,304
| +13% | +$11.8M | 0.01% | 1092 |
|
|
2020
Q3 | $85M | Buy |
3,018,831
+185,979
| +7% | +$5.37M | 0.01% | 988 |
|
|
2020
Q2 | $80.1M | Buy |
+2,832,852
| New | +$81.7M | 0.01% | 974 |
|
Other funds holding RNAM
Fidelity Investments's RNAM Position: Q1 2026 in Review
Fidelity Investments sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 183,229 shares — an estimated $13.2M sold.
Fidelity Investments first reported a position in RNAM in Q2 2020 and held it in 23 quarters. The position peaked at $941M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Fidelity Investments reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Fidelity Investments sold 183,229 Avidity Biosciences shares in Q1 2026, an estimated $13.2M.
- Fidelity Investments first reported a position in Avidity Biosciences in Q2 2020 and held it in 23 quarters.
- Fidelity Investments's Avidity Biosciences position peaked at $941M in Q3 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.